Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.

Creator(s)

Ahmad H. Ali
Cynthia W. Buness
Ryan T. Fischer, Children's Mercy HospitalFollow
Gerald J. Holtmann
Ayesha Shah
Peter Lewindon
Shamita Shah
Amol S. Ragnekar
Amy E. Taylor
Aparna Goel
Kenneth L. Cox
Leina Alrabadi
Steve Wadsworth
Sakil S. Kulkarni
Keith D. Lindor

Document Type

Letter to the Editor

Publication Date

6-1-2023

Identifier

DOI: 10.1097/HEP.0000000000000304

Journal Title

Hepatology (Baltimore, Md.)

Volume

77

Issue

6

First Page

174

Last Page

175

MeSH Keywords

Humans; Vancomycin; Cholangitis, Sclerosing; Anti-Bacterial Agents; Insurance

Keywords

Vancomycin; Sclerosing Cholangitis; Anti-Bacterial Agents; Insurance

Recommended Citation

Ali AH, Buness CW, Fischer R, et al. Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023;77(6):E174-E175. doi:10.1097/HEP.0000000000000304